Psilocybin for Prolonged Grief Disorder — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Psilocybin for Prolonged Grief Disorder — Stella

Home/Prolonged Grief Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Prolonged Grief Disorder trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

University of Virginia, Charlottesville, Virginia

Key details

Phase

Very early testing

Sponsor

University of Virginia

Collaborators

Tiny Blue Dot Foundation, Texas Tech University

Enrollment target

~12 participants

Started

March 2026

Primary completion

August 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 65 Years

Last updated March 2026